ClinicalTrials.Veeva

Menu

Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy

S

Shiraz University of Medical Sciences

Status and phase

Completed
Phase 2

Conditions

Contrast Induced Nephropathy

Treatments

Drug: sodium bicarbonate
Drug: Acetazolamide
Drug: normal salin

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is whether Acetazolamide is effective in prevention of contrast nephropathy

Full description

Contrast induced nephropathy is one of common causes of acute renal failure many preventive protocol existed . 240 patient that underwent coronary angiography randomly divided in three groups.Group 1,2,3 will receive Bicarbonate ,Acetazolamide+Normal salin and Normal salin respectively.We compare prevalence of contrast nephropathy in each group.

Enrollment

240 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patient that underwent coronary angiography

Exclusion criteria

  • serum Cr. more than 3 mg/dl
  • electrolyte and acid-base imbalance
  • pulmonary edema
  • allergy to Acetazolamide

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

240 participants in 3 patient groups

1
Active Comparator group
Description:
150 meq/l NaHco3 3cc/kg/hr one Hour before and 1cc/kg/hr 6 hour after angiography
Treatment:
Drug: sodium bicarbonate
2
Active Comparator group
Description:
Acetazolamide 250 mg + 1cc/kg/hr normal salin 6 hour before and after angiography
Treatment:
Drug: Acetazolamide
3
Active Comparator group
Description:
normal salin 1cc/kg/hr before and after angiography
Treatment:
Drug: normal salin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems